Latham & Watkins LLP represented the underwriters in the offering. Aclaris Therapeutics, Inc. completed its underwritten public offering of 5,483,714 shares of its common stock at…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now